CRL 📈 Charles River Laboratories - Overview

Charles River Laboratories International, Inc. is a leading provider of essential services and products that support the discovery, development, and safety of new drugs and therapies. With operations spanning the United States, Europe, Canada, the Asia Pacific, and other international locations, the company plays a critical role in the global healthcare ecosystem. Its business is organized into three primary segments: Research Models and Services, Discovery and Safety Assessment, and Manufacturing Solutions. The Research Models and Services segment is a key supplier of high-quality research models, including rodents and purpose-bred rats and mice, which are used by researchers to advance medical science and develop new treatments.

The company's Discovery and Safety Assessment segment offers a comprehensive suite of services designed to support the early stages of drug discovery and development. This includes in vivo and in vitro testing, toxicology, pathology, and other specialized services that help clients identify and validate novel targets, chemical compounds, and antibodies. By providing these services, Charles River Laboratories enables its clients to efficiently and effectively advance their drug candidates through the preclinical development process. The segment's capabilities also extend to safety assessment services, such as bioanalysis, drug metabolism, and pharmacokinetics, which are critical for ensuring the safety and efficacy of new drugs and therapies.

The Manufacturing segment of Charles River Laboratories provides specialized testing and manufacturing services to pharmaceutical and biotechnology companies. This includes in vitro methods for quality control testing of pharmaceuticals and consumer products, as well as specialized testing of biologics. The company also offers contract vivarium operation services, which enable biopharmaceutical clients to outsource the management of their research animal facilities. By providing these services, Charles River Laboratories helps its clients to streamline their operations, reduce costs, and improve efficiency. With a rich history dating back to 1947, the company has established itself as a trusted partner to the global healthcare industry, with a strong reputation for quality, reliability, and expertise.

As a publicly traded company listed on the New York Stock Exchange (NYSE) under the ticker symbol CRL, Charles River Laboratories is committed to delivering long-term value to its shareholders. The company's common stock is classified under the GICS Sub Industry category of Life Sciences Tools & Services, reflecting its focus on providing essential products and services to the healthcare industry. With its global operations, diversified business segments, and commitment to innovation and quality, Charles River Laboratories is well-positioned to continue playing a leading role in the development of new drugs and therapies that improve human health and well-being. For more information about the company, please visit its website at https://www.criver.com, or review its financial and operational performance as reported under the ISIN code US1598641074.